Aclarion Expands Nociscan Access with New Partnership in Louisiana
BROOMFIELD, Colo., April 29, 2025 – Aclarion, Inc. (Nasdaq: ACON, ACONW), a healthcare technology company specializing in chronic low back pain solutions, has finalized a commercial agreement with the Spine Institute of Louisiana (SIL) in Shreveport, LA. This partnership marks a significant milestone, making Nociscan available in Louisiana through one of the nation’s leading spine organizations.
Dr. Pierce Nunley of SIL emphasized the importance of Nociscan, noting its role in accurately identifying pain sources linked to chronic back issues. With SIL’s five board-certified surgeons utilizing Nociscan, the innovative platform is expected to enhance patient care and surgical outcomes.
This development brings the total number of Nociscan centers to 17, spanning eight states and four countries. Aclarion’s CEO, Brent Ness, expressed enthusiasm over integrating Nociscan with Philips MR Spectroscopy (MRS), highlighting the technology’s seamless application across multiple platforms.
Nociscan, the first evidence-supported SaaS platform of its kind, distinguishes between painful and nonpainful lumbar discs, demonstrating a notable 97% surgical success rate when treating identified painful discs. As over 266 million individuals globally grapple with degenerative spine issues, Aclarion is poised to provide critical insights for both patients and medical professionals.
For further details, visit Aclarion’s website.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
